Literature DB >> 974660

Muscle changes in acromegaly.

M Nagulesparen, R Trickey, M J Davies, J S Jenkins.   

Abstract

Muscle biopsy specimens were obtained from 18 patients with acromegaly of varying degrees of severity. Half the specimens showed hypertrophy of type 1 fibres, while atrophy was most often seen in type 2 fibres. A direct correlation between muscle appearances and growth hormone levels was not observed. The needle biopsy technique is particularly suitable for determining the natural history of acrometalic myopathy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974660      PMCID: PMC1688457          DOI: 10.1136/bmj.2.6041.914

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Muscle performance in rats, normal and treated with growth hormone.

Authors:  B BIGLAND; B JEHRING
Journal:  J Physiol       Date:  1952-02       Impact factor: 5.182

2.  Pathological changes in skeletal muscle in acromegaly.

Authors:  F L Mastaglia
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

  2 in total
  18 in total

1.  Static and dynamic balances of patients with acromegaly and impact of exercise on balance.

Authors:  Ozlem Haliloglu; Nuri Topsakal; Filiz Camliguney; Ozge Polat Korkmaz; Serdar Sahin; Birol Cotuk; Pinar Kadioglu; Oya Erkut
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

2.  Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model.

Authors:  C Semsarian; P Sutrave; D R Richmond; R M Graham
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  [Congenital and endogenous endocrine myopathy].

Authors:  S Wenninger; B Schoser
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

4.  Nocturnal prolactin secretion in carpal tunnel syndrome.

Authors:  E Rossi; E Sighinolfi; P Bortolotti; G De Santis; R Schoenhuber; M Grandi; A Landi
Journal:  Ital J Neurol Sci       Date:  1984-12

5.  Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry.

Authors:  Pamela U Freda; Wei Shen; Carlos M Reyes-Vidal; Eliza B Geer; Fernando Arias-Mendoza; Dympna Gallagher; Steven B Heymsfield
Journal:  J Clin Endocrinol Metab       Date:  2009-06-02       Impact factor: 5.958

6.  Alterations in body composition in acromegaly.

Authors:  Laurence Katznelson
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 7.  Growth hormone and athletes.

Authors:  J G Macintyre
Journal:  Sports Med       Date:  1987 Mar-Apr       Impact factor: 11.136

Review 8.  Regulation of muscle mass by growth hormone and IGF-I.

Authors:  C P Velloso
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

9.  Chronic myopathy due to immunoglobulin light chain amyloidosis.

Authors:  Irini Manoli; Justin Y Kwan; Qian Wang; Elisabeth J Rushing; Maria Tsokos; Andrew E Arai; Warner M Burch; Angela Dispenzieri; Alexandra C McPherron; William A Gahl
Journal:  Mol Genet Metab       Date:  2013-02-04       Impact factor: 4.797

10.  Restrictive extraocular myopathy: a presenting feature of acromegaly.

Authors:  Steven Heireman; Christophe Delaey; Ilse Claerhout; Christian E Decock
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.